The Patent Finder

Rhodes Pharmaceuticals L.P.

Also on record
Records under this name other than the patents Rhodes Pharmaceuticals L.P. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.

Back to Rhodes Pharmaceuticals L.P.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,571,392Systems and Methods for Increasing Stability of Dronabinol Compositions
Held by another company
In force
 · High confidence
In forceHigh confidence
US 9,861,628Buprenorphine Wafer for Drug Substitution Therapy
Lapsed on the fee record
Ended Jan 9, 2026 · High confidence
Lapsed on the fee recordEnded Jan 9, 2026High confidence
US 9,763,931Buprenorphine-Wafer for Drug Substitution Therapy
Lapsed on the fee record
Ended Sep 19, 2025 · High confidence
Lapsed on the fee recordEnded Sep 19, 2025High confidence
US 8,580,310Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
Term ended
Term ended Apr 12, 2022 · USPTO record
Term endedTerm ended Apr 12, 2022USPTO record
US 6,589,960Hydromorphone and Hydrocodone Compositions and Methods for Their Synthesis
Term ended
Term ended Nov 9, 2020 · Medium confidence
Term endedTerm ended Nov 9, 2020Medium confidence
US 6,419,960Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
Term ended
Term ended Dec 16, 2019 · USPTO record
Term endedTerm ended Dec 16, 2019USPTO record
US 6,673,367Controlled/modified release oral methylphenidate formulations
Term ended
Term ended Dec 16, 2019 · USPTO record
Term endedTerm ended Dec 16, 2019USPTO record
US 7,083,808Controlled/modified release oral methylphenidate formulations
Term ended
Term ended Dec 16, 2019 · USPTO record
Term endedTerm ended Dec 16, 2019USPTO record
US 7,247,318Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
Term ended
Ended no later than Dec 16, 2019 · USPTO record
Term endedEnded no later than Dec 16, 2019USPTO record
US 7,438,930Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
Term ended
Ended no later than Dec 16, 2019 · USPTO record
Term endedEnded no later than Dec 16, 2019USPTO record
10 of 16 patents shown.
Pro members see all 16.
Pro members: see all 16 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited